Rezolute, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Rezolute, Inc. is a late-stage biotechnology company focused on developing therapies for rare diseases, specifically targeting hypoglycemia caused by hyperinsulinism. Its work centers on improving clinical outcomes for individuals affected by HI, with the primary clinical compound RZ358 cited in preclinical contexts. The company operates from Redwood City, California, and positions itself within the biotechnology research sector as a late-stage program developer addressing unmet medical needs in rare disorders. Rezolute engages with a professional audience and participates in industry conferences and events to share its progress, reflecting an emphasis on advancing translational research toward therapeutic options for HI-related hypoglycemia. Recent activity includes management participation in industry conferences and the addition of new leadership to support commercialization and strategic development efforts.